Treatment of tics and tourette syndrome

Current Treatment Options in Neurology

Volumn 12, Issue 6, 2010, Pages 539-561

  Singer, Harvey S ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BACLOFEN; BOTULINUM TOXIN; BOTULINUM TOXIN A; CANNABIS; CLONAZEPAM; CLONIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; ETIRACETAM; FLUPHENAZINE; GUANFACINE; HALOPERIDOL; IMMUNOMODULATING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PERGOLIDE; PIMOZIDE; PLACEBO; PSYCHOSTIMULANT AGENT; QUETIAPINE; RISPERIDONE; SULPIRIDE; TETRABENAZINE; TIAPRIDE; TOPIRAMATE; TRIFLUOPERAZINE; UNINDEXED DRUG; ZIPRASIDONE;

ACUPUNCTURE; AGGRESSION; AGITATION; AKATHISIA; ANXIETY DISORDER; ATAXIA; ATTENTION DEFICIT DISORDER; AUTOMUTILATION; BEDTIME DOSAGE; BEHAVIOR THERAPY; BLURRED VISION; BODY TEMPERATURE DISORDER; BRADYKINESIA; BRAIN DEPTH STIMULATION; CEREBROVASCULAR ACCIDENT; CHRONIC MOTOR TIC DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; COMPREHENSIVE BEHAVIORAL INTERVENTION FOR TIC; CONCENTRATION LOSS; CONFUSION; CONSTIPATION; CONTINGENCY MANAGEMENT; DEPRESSION; DIABETES MELLITUS; DIET THERAPY; DIPLOPIA; DISEASE ASSOCIATION; DISEASE COURSE; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE SEQUENCE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSLIPIDEMIA; DYSPHASIA; DYSPHONIA; DYSPHORIA; DYSTONIA; ECCHYMOSIS; ELECTROCARDIOGRAPHY; ENDOCRINE DISEASE; EUPHORIA; EVENING DOSAGE; EXTRAPYRAMIDAL SYMPTOM; FAMILY COUNSELING; FATIGUE; GALACTORRHEA; GASTROINTESTINAL SYMPTOM; GILLES DE LA TOURETTE SYNDROME; GLUCOSE METABOLISM; GYNECOMASTIA; HABIT REVERSAL TRAINING; HALLUCINATION; HEADACHE; HEART CONDUCTION; HEART DEATH; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERACTIVITY; HYPERGLYCEMIA; HYPERPROLACTINEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE RASH; INSOMNIA; INTELLECTUAL IMPAIRMENT; IRRITABILITY; LACTATION; LOW DRUG DOSE; MEMORY DISORDER; MENTAL INSTABILITY; METABOLIC DISORDER; MONOTHERAPY; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; NAUSEA; NERVOUSNESS; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC DISEASE; NEUROSURGERY; OBESITY; OBSESSIVE COMPULSIVE DISORDER; OCULOGYRIC CRISIS; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PARKINSON DISEASE; PARKINSONISM; PATIENT ASSESSMENT; PATIENT EDUCATION; PERSONALITY DISORDER; PHOBIA; PHOTOSENSITIVITY DISORDER; PLEURAL FIBROSIS; QT PROLONGATION; RECOMMENDED DRUG DOSE; RELAXATION TRAINING; REPEAT PROCEDURE; RESPIRATION DEPRESSION; RESTLESSNESS; RETINOPATHY; RETROPERITONEAL FIBROSIS; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SINGLE DRUG DOSE; SKIN IRRITATION; SLEEP DISORDER; SOMATIZATION; SOMNOLENCE; SPASTICITY; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TACHYCARDIA; TARDIVE DYSKINESIA; TASTE DISORDER; THERAPY EFFECT; TIC; TIC DISORDER NOT OTHERWISE SPECIFIED; TRANSCRANIAL MAGNETIC STIMULATION; TRANSIENT TIC DISORDER; TREATMENT INDICATION; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; VALVULAR HEART DISEASE; VASOSPASM; VISUAL DISORDER; VOCAL TIC; VOMITING; WEAKNESS; WEIGHT GAIN; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 77958464003     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-010-0095-4     Document Type: Review

References (91)

1. HS Singer 2005 Tourette's syndrome: from behaviour to biology Lancet Neurol 4 149 159 15721825
2. JT Walkup Y Ferrao JF Leckman, et al. 2010 Tic disorders: some key issues for DSM-V Depress Anxiety 27 600 610 10.1002/da.20711 20533370 This article reviews new proposals for the classification of tic disorders.
3. N Khalifa AL von Knorring 2005 Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background Acta Paediatr 94 1608 1614 10.1080/08035250510043879 16352498 (Pubitemid 41754315)
4. R Kurlan PG Como B Miller, et al. 2002 The behavioral spectrum of tic disorders: a community-based study Neurology 59 414 420 12177376 1:STN:280:DC%2BD38vitV2qsA%3D%3D
5. AE Cavanna C Eddy HE Rickards 2009 Cognitive functioning in Tourette syndrome Discov Med 8 191 195 20040269
6. T Pringsheim A Lang R Kurlan, et al. 2009 Understanding disability in Tourette syndrome Dev Med Child Neurol 51 468 472 10.1111/j.1469-8749.2008. 03168.x 19018838 This study emphasizes the importance of comorbidity in the psychosocial health of children with TS and suggests that the treatment of ADHD and OCD should be a priority in children with multiple diagnoses.
7. NI Mejia J Jankovic 2005 Secondary tics and tourettism Rev Bras Psiquiatr 27 11 17 15867978
8. A Bergin HR Waranch J Brown, et al. 1998 Relaxation therapy in Tourette syndrome: a pilot study Pediatr Neurol 18 136 142 10.1016/S0887-8994(97)00200-2 9535299 1:STN:280:DyaK1c7psV2nug%3D%3D (Pubitemid 28125411)
9. KP O'Connor A Laverdure A Taillon, et al. 2009 Cognitive behavioral management of Tourette's syndrome and chronic tic disorder in medicated and unmedicated samples Behav Res Ther 47 1090 1095 10.1016/j.brat.2009.07.021 19698938
10. Woods DW, Piacentini JC, Chang SW, et al.: Managing Tourette Syndrome: A Behavioral Intervention for Children and Adults. New York: Oxford University Press; 2008. Woods DW, Piacentini JC, Chang SW, et al.: Managing Tourette Syndrome: A Behavioral Intervention for Children and Adults. New York: Oxford University Press; 2008.
11. MB Himle DW Woods JC Piacentini JT Walkup 2006 Brief review of habit reversal training for Tourette syndrome J Child Neurol 21 719 725 10.1177/08830738060210080101 16970874 (Pubitemid 44295132)
12. T Deckersbach S Rauch U Buhlmann S Wilhelm 2006 Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response Behav Res Ther 44 1079 1090 10.1016/j.brat.2005.08.007 16259942 (Pubitemid 43949248)
13. J Piacentini DW Woods L Scahill, et al. 2010 Behavior therapy for children with Tourette disorder: a randomized controlled trial JAMA 303 1929 1937 10.1001/jama.2010.607 20483969 1:CAS:528:DC%2BC3cXmtl2mu7s%3D This controlled trial showed that comprehensive behavioral therapy was superior to supportive therapy and education in the reduction of tics.
14. R Garcia-Lopez J Romero-Gonzalez E Perea-Milla, et al. 2008 An open study evaluating the efficacy and security of magnesium and vitamin B(6) as a treatment of Tourette syndrome in children. Med Clin (Barc) 131 689 692 10.1157/13129113
15. S Ma XY Liu RL Yu LJ Chen 2006 Clinical observation on acupuncture for treatment of Tourette's syndrome Zhongguo Zhen Jiu 26 392 394 16813178
16. A Mantovani SH Lisanby F Pieraccini, et al. 2006 Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS) Int J Neuropsychopharmacol 9 95 100 10.1017/S1461145705005729 15982444 (Pubitemid 43068339)
17. A Mantovani JF Leckman H Grantz, et al. 2007 Repetitive transcranial magnetic stimulation of the supplementary motor area in the treatment of Tourette syndrome: report of two cases Clin Neurophysiol 118 2314 2315 10.1016/j.clinph.2007.07.011 17709291 (Pubitemid 47385357)
18. L Scahill G Erenberg CM Berlin Jr, et al. 2006 Contemporary assessment and pharmacotherapy of Tourette syndrome NeuroRx 3 192 206 10.1016/j.nurx.2006. 01.009 16554257 1:CAS:528:DC%2BD28XhtFKqur7O A valuable guide to clinical assessment and a comprehensive review of earlier published literature on the pharmacological treatment of Tourette syndrome, ADHD and OCD. (Pubitemid 44061705)
19. Tourette's Syndrome Study Group 2002 Treatment of ADHD in children with tics: a randomized controlled trial Neurology 58 527 536 This study evaluated the effect of methylphenidate and clonidine in children with ADHD and showed that methylphenidate did not exacerbate tics and that clonidine was beneficial for ADHD.
20. EF Hedderick CM Morris HS Singer 2009 Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome Pediatr Neurol 40 420 425 10.1016/j.pediatrneurol.2008.12.014 19433274
21. GR Gaffney PJ Perry BC Lund, et al. 2002 Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome J Am Acad Child Adolesc Psychiatry 41 330 336 10.1097/00004583-200203000-00013 11886028 (Pubitemid 38338155)
22. YS Du HF Li A Vance, et al. 2008 Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders Aust NZ J Psychiatry 42 807 813 10.1080/ 00048670802277222
23. MH Bloch KE Panza A Landeros-Weisenberger JF Leckman 2009 Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders J Am Acad Child Adolesc Psychiatry 48 884 893 10.1097/CHI. 0b013e3181b26e9f 19625978 This meta-analysis reviews double-blind, randomized, placebo-controlled trials examining the efficacy of different medications in the treatment of ADHD in children with comorbid tics
24. L Scahill PB Chappell YS Kim, et al. 2001 A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder Am J Psychiatry 158 1067 1074 10.1176/appi.ajp.158.7. 1067 11431228 1:STN:280:DC%2BD3MznsVegtQ%3D%3D (Pubitemid 32623110)
25. DD Cummings HS Singer M Krieger, et al. 2002 Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study Clin Neuropharmacol 25 325 332 10.1097/00002826-200211000-00009 12469007 1:CAS:528:DC%2BD38Xptlehsbc%3D (Pubitemid 36025273)
26. FS Abuzzahab VL Brown 2001 Control of Tourette's syndrome with topiramate Am J Psychiatry 158 968 11384920 1:STN:280:DC%2BD3MzhtFClsw%3D%3D
27. SH Kuo J Jimenez-Shahed 2010 Topiramate in treatment of Tourette syndrome Clin Neuropharmacol 33 32 34 10.1097/WNF.0b013e3181c295c1 19935407 1:CAS:528:DC%2BC3cXht12gtLk%3D
28. J Jankovic J Jimenez-Shahed LW Brown 2009 A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome J Neurol Neurosurg Psychiatry 81 70 73 10.1136/jnnp.2009.185348 19726418
29. Y Awaad AM Michon S Minarik 2005 Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome Mov Disord 20 714 718 10.1002/mds.20385 15704204 (Pubitemid 41056938)
30. A Fernandez-Jaen DM Fernandez-Mayoralas N Munoz-Jareno B Calleja-Perez 2009 An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome Eur J Paediatr Neurol 13 541 545 10.1016/j.ejpn.2008.12.006 19211282
31. CL Smith-Hicks DD Bridges NP Paynter HS Singer 2007 A double blind randomized placebo control trial of levetiracetam in Tourette syndrome Mov Disord 22 1764 1770 10.1002/mds.21615 17566124 (Pubitemid 47597600)
32. Shapiro AK: Gilles de la Tourette Syndrome. New York: Raven; 1988.
33. Y Awaad 1999 Tics in Tourette syndrome: new treatment options J Child Neurol 14 316 319 10.1177/088307389901400508 10342599 1:STN:280: DyaK1M3nt1ShtQ%3D%3D
34. HS Singer J Wendlandt M Krieger J Giuliano 2001 Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial Neurology 56 599 604 11245709 1:CAS:528:DC%2BD3MXitlCjsb8%3D
35. I Drtilkova B Balaotkova H Lemanova J Zak 1994 Therapeutical effects of clonidine and clonazepam in children with tic syndrome Homeost Health Dis 35 296
36. WA Ray CP Chung KT Murray, et al. 2009 Atypical antipsychotic drugs and the risk of sudden cardiac death N Engl J Med 360 225 235 10.1056/NEJMoa0806994 19144938 1:CAS:528:DC%2BD1MXnsFCjsg%3D%3D This study calculated the adjusted incidence of sudden cardiac death among users of antipsychotic drugs in a retrospective cohort study of Medicaid enrollees in Tennessee. Data showed that users of typical and atypical antipsychotic drugs had a similar, dose-related increase of sudden cardiac death
37. S Schneeweiss J Avorn 2009 Antipsychotic agents and sudden cardiac death-How should we manage the risk? N Engl J Med 360 294 296 10.1056/NEJMe0809417 19144946 1:CAS:528:DC%2BD1MXns1OisA%3D%3D
38. Pringsheim T, Marras C: Pimozide for tics in Tourette's syndrome. Cochrane Database Syst Rev 2009, CD006996. This comprehensive review of prior studies assessed the benefits and risks of pimozide in comparison to placebo or other medications in treating tics in Tourette syndrome.
39. HS Singer K Gammon S Quaskey 1985 Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment Pediatr Neurosci 12 71 74 10.1159/000120222 3870139
40. CG Goetz CM Tanner HL Klawans 1984 Fluphenazine and multifocal tic disorders Arch Neurol 41 271 272 6582810 1:STN:280:DyaL2c7islCmtg%3D%3D
41. J Jankovic 2009 Treatment of hyperkinetic movement disorders Lancet Neurol 8 844 856 10.1016/S1474-4422(09)70183-8 19679276 1:CAS:528: DC%2BD1MXhtFaksbfL
42. E Shapiro AK Shapiro G Fulop, et al. 1989 Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome Arch Gen Psychiatry 46 722 730 2665687 1:STN:280:DyaL1MzitFOmuw%3D%3D
43. L Scahill JF Leckman RT Schultz, et al. 2003 A placebo-controlled trial of risperidone in Tourette syndrome Neurology 60 1130 1135 10.1001/archneur.60. 8.1130 12682319 1:STN:280:DC%2BD3s7msFShsA%3D%3D (Pubitemid 36975803)
44. Y Dion L Annable P Sandor G Chouinard 2002 Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial J Clin Psychopharmacol 22 31 39 10.1097/00004714-200202000-00006 11799340 1:CAS:528:DC%2BD38Xht1yku7o%3D (Pubitemid 34101290)
45. R Bruggeman C van der Linden JK Buitelaar, et al. 2001 Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study J Clin Psychiatry 62 50 56 10.4088/JCP.v62n0111 11235929 1:CAS:528:DC%2BD3MXhsVWqs7s%3D
46. DL Gilbert JR Batterson G Sethuraman FR Sallee 2004 Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial J Am Acad Child Adolesc Psychiatry 43 206 214 10.1097/00004583-200402000-00017 14726728
47. C Budman BJ Coffey R Shechter, et al. 2008 Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts J Child Adolesc Psychopharmacol 18 509 515 10.1089/cap.2007.061 18928415
48. W Kawohl F Schneider I Vernaleken I Neuner 2009 Chronic motor tic disorder and aripiprazole J Neuropsychiatry Clin Neurosci 21 224 19622695
49. TK Murphy PJ Mutch JM Reid, et al. 2009 Open label aripiprazole in the treatment of youth with tic disorders J Child Adolesc Psychopharmacol 19 441 447 10.1089/cap.2008.0149 19702496
50. L Davies JS Stern N Agrawal MM Robertson 2006 A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole Hum Psychopharmacol 21 447 453 10.1002/hup.798 17029306 1:CAS:528:DC%2BD28Xht1Kls7zO (Pubitemid 44660184)
51. WS Seo HM Sung HS Sea DS Bai 2008 Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder J Child Adolesc Psychopharmacol 18 197 205 10.1089/cap.2007.0064 18439116 (Pubitemid 351591440)
52. FR Sallee R Kurlan CG Goetz, et al. 2000 Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study J Am Acad Child Adolesc Psychiatry 39 292 299 10.1097/00004583-200003000-00010 10714048 1:STN:280:DC%2BD3c7nvVeqtA%3D%3D
53. G Willmund AH Lee F Wertenauer, et al. 2009 Vocal tics associated with ziprasidone J Clin Psychopharmacol 29 611 612 10.1097/JCP.0b013e3181c06dad 19910734
54. CL Budman A Gayer M Lesser, et al. 2001 An open-label study of the treatment efficacy of olanzapine for Tourette's disorder J Clin Psychiatry 62 290 294 10.4088/JCP.v62n0412 11379844 1:CAS:528:DC%2BD3MXkt1CmsLs%3D
55. JT McCracken R Suddath S Chang, et al. 2008 Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome J Child Adolesc Psychopharmacol 18 501 508 10.1089/cap.2007.135 18928414
56. M Onofrj C Paci G D'Andreamatteo L Toma 2000 Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide J Neurol 247 443 446 10.1007/s004150070173 10929273 1:STN:280:DC%2BD3M%2FktVygtA%3D%3D (Pubitemid 30433558)
57. NM Mukaddes O Abali 2003 Quetiapine treatment of children and adolescents with Tourette's disorder J Child Adolesc Psychopharmacol 13 295 299 10.1089/104454603322572624 14642017
58. M Copur B Arpaci T Demir H Narin 2007 Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome: a retrospective case-note survey Clin Drug Investig 27 123 130 10.2165/00044011-200727020-00005 17217317 1:CAS:528:DC%2BD2sXis1yntLY%3D (Pubitemid 46143287)
59. C Kenney C Hunter J Jankovic 2007 Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders Mov Disord 22 193 197 10.1002/mds.21222 17133512 (Pubitemid 46374760)
60. C Kenney C Hunter A Davidson J Jankovic 2007 Short-term effects of tetrabenazine on chorea associated with Huntington's disease Mov Disord 22 10 13 10.1002/mds.21161 17078062 (Pubitemid 46382667)
61. M Porta M Sassi M Cavallazzi, et al. 2008 Tourette's syndrome and role of tetrabenazine: review and personal experience Clin Drug Investig 28 443 459 10.2165/00044011-200828070-00006 18544005 1:CAS:528:DC%2BD1cXovFelsLs%3D (Pubitemid 351821482)
62. DM Simpson A Blitzer A Brashear, et al. 2008 Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 70 1699 1706 10.1212/01.wnl.0000311389. 26145.95 18458230 1:CAS:528:DC%2BD1cXnsFGgtrs%3D This report includes an evidence-based review of the use of botulinum toxin (Botox) in treating tics. (Pubitemid 351644138)
63. C Marras D Andrews E Sime AE Lang 2001 Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial Neurology 56 605 610 11245710 1:CAS:528:DC%2BD3MXitlCjsbw%3D
64. CH Kwak PA Hanna J Jankovic 2000 Botulinum toxin in the treatment of tics Arch Neurol 57 1190 1193 10.1001/archneur.57.8.1190 10927800 1:STN:280:DC%2BD3cvisVWrsg%3D%3D
65. JJ Rath DL Tavy AA Wertenbroek, et al. 2010 Botulinum toxin type A in simple motor tics: short-term and long-term treatment-effects Parkinsonism Relat Disord 16 478 481 10.1016/j.parkreldis.2009.11.011 20034838
66. M Porta G Maggioni F Ottaviani A Schindler 2004 Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A Neurol Sci 24 420 423 10.1007/s10072-003-0201-4 14767691 1:STN:280:DC%2BD2c%2Fms1aqtQ%3D%3D (Pubitemid 38256251)
67. MM Robertson V Schnieden AJ Lees 1990 Management of Gilles de la Tourette syndrome using sulpiride Clin Neuropharmacol 13 229 235 10.1097/00002826- 199006000-00005 2357704 1:STN:280:DyaK3c3ptFCitA%3D%3D
68. CS Ho HJ Chen NC Chiu, et al. 2009 Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder J Formos Med Assoc 108 788 793 10.1016/S0929-6646(09)60406-X 19864199 1:CAS:528:DC%2BD1MXhsFentLrL
69. C Eggers A Rothenberger U Berghaus 1988 Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride Eur Arch Psychiatry Neurol Sci 237 223 229 10.1007/BF00449911 2974416 1:STN:280:DyaL1M%2FnvVChtw%3D%3D
70. KR Muller-Vahl U Schneider H Prevedel, et al. 2003 Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial J Clin Psychiatry 64 459 465 10.4088/JCP.v64n0417 12716250
71. HS Singer C Morris M Grados 2010 Glutamatergic modulatory therapy for Tourette syndrome Med Hypotheses 74 862 867 10.1016/j.mehy.2009.11.028 20022434 1:CAS:528:DC%2BC3cXktlCktLw%3D
72. E Cubo 2008 Fernandez Jaen A, Moreno C, et al.: Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study Clin Ther 30 182 189 10.1016/j.clinthera.2008.01.010 18343255 1:CAS:528: DC%2BD1cXhtVWltL7M (Pubitemid 351834724)
73. M Bortolato A Muroni F Marrosu 2007 Treatment of Tourette's syndrome with finasteride Am J Psychiatry 164 1914 1915 10.1176/appi.ajp.2007.07060978 18056252 (Pubitemid 351739253)
74. BS Peterson H Zhang GM Anderson JF Leckman 1998 A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome J Clin Psychopharmacol 18 324 331 10.1097/00004714- 199808000-00013 9690699 1:CAS:528:DyaK1cXltFSmsL8%3D (Pubitemid 28353876)
75. P Toren A Weizman S Ratner, et al. 2005 Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study J Clin Psychiatry 66 499 503 10.4088/JCP.v66n0413 15816793 1:CAS:528:DC%2BD2MXktlWqs70%3D
76. C Bonnier MC Nassogne P Evrard 1999 Ketanserin treatment of Tourette's syndrome in children Am J Psychiatry 156 1122 1123 10401479 1:STN:280: DyaK1MzivFOhsA%3D%3D
77. SJ Perlmutter SF Leitman MA Garvey, et al. 1999 Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood Lancet 354 1153 1158 10.1016/S0140-6736(98)12297-3 10513708 1:STN:280:DyaK1MvktFyltA%3D%3D (Pubitemid 29460444)
78. PJ Hoekstra RB Minderaa CG Kallenberg 2004 Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study J Clin Psychiatry 65 537 542 10.4088/JCP.v65n0413 15119917 1:CAS:528: DC%2BD2cXkslOltLs%3D
79. JS Neimat PG Patil AM Lozano 2006 Novel surgical therapies for Tourette syndrome J Child Neurol 21 715 718 10.1177/08830738060210080301 16970873 (Pubitemid 44295131)
80. M Porta M Sassi F Ali, et al. 2009 Neurosurgical treatment for Gilles de la Tourette syndrome: the Italian perspective J Psychosom Res 67 585 590 10.1016/j.jpsychores.2009.06.001 19913662 This review of prior studies suggests that although deep brain stimulation is a promising neurosurgical procedure for the treatment of tics, several issues remain to be resolved.
81. JW Mink 2009 Clinical review of DBS for Tourette syndrome Front Biosci (Elite Ed) 1 72 76
82. ML Welter L Mallet JL Houeto, et al. 2008 Internal pallidal and thalamic stimulation in patients with Tourette syndrome Arch Neurol 65 952 957 10.1001/archneur.65.7.952 18625864 (Pubitemid 352008480)
83. DC Shields ML Cheng AW Flaherty, et al. 2008 Microelectrode-guided deep brain stimulation for Tourette syndrome: within-subject comparison of different stimulation sites Stereotact Funct Neurosurg 86 87 91 10.1159/000112429 18073521 (Pubitemid 351341534)
84. Y Temel V Visser-Vandewalle 2004 Surgery in Tourette syndrome. Mov Disord 19 3 14 10.1002/mds.10649 (Pubitemid 38559615)
85. V Roessner M Robatzek G Knapp, et al. 2006 First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants Dev Med Child Neurol 48 616 621 10.1017/S0012162206001290 16780635
86. G Erenberg 2005 The relationship between Tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review Semin Pediatr Neurol 12 217 221 10.1016/j.spen.2005.12.003 16780292 (Pubitemid 43850348)
87. AJ Allen RM Kurlan DL Gilbert, et al. 2005 Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders Neurology 65 1941 1949 10.1212/01.wnl.0000188869.58300.a7 16380617 1:CAS:528:DC%2BD2MXht12jsbjI (Pubitemid 43970115)
88. HS Singer J Brown S Quaskey, et al. 1995 The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine Pediatrics 95 74 81 7770313 1:STN:280:DyaK2M3ovVWgtg%3D%3D
89. T Spencer J Biederman B Coffey, et al. 2002 A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder Arch Gen Psychiatry 59 649 656 10.1001/archpsyc.59.7.649 12090818 1:CAS:528:DC%2BD38XlvVSisLw%3D
90. EA Storch T Bjorgvinsson B Riemann, et al. 2010 Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder Bull Menninger Clin 74 167 185 10.1521/bumc.2010.74.2.167 20545494
91. EH Decloedt DJ Stein 2010 Current trends in drug treatment of obsessive-compulsive disorder Neuropsychiatr Dis Treat 6 233 242 10.2147/NDT.S3149 20520787 1:CAS:528:DC%2BC3cXms1Wmsro%3D